Abstract: Cardiac troponin is a dynamic complex of troponin C, troponin I, and troponin T (TnC, TnI, and TnT, respectively) found in the myocyte thin filament where it plays an essential role in cardiac muscle contraction. Mutations in troponin subunits are found in inherited cardiomyopathies, such as hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). The highly dynamic nature of human cardiac troponin and presence of numerous flexible linkers in its subunits suggest that understanding of structural and functional properties of this important complex can benefit from the consideration of the protein intrinsic disorder phenomenon. We show here that mutations causing decrease in the disorder score in TnI and TnT are significantly more abundant in HCM and DCM than mutations leading to the increase in the disorder score. Identification and annotation of intrinsically disordered regions in each of the troponin subunits conducted in this study can help in better understanding of the roles of intrinsic disorder in regulation of interactomes and posttranslational modifications of these proteins. These observations suggest that disease-causing mutations leading to a decrease in the local flexibility of troponins can trigger a whole plethora of functional changes in the heart.
Introduction
Cardiomyopathy is a malfunction of the heart muscle and it encompasses groups of heart structural changes caused by a variety of disorders or genetic alterations. Unfortunately, some of the genetic causes leading to this disease are still not fully understood and the etiology of the cardiomyopathy remains vastly idiopathic (Sturm, 2013) . This has prompted us to investigate this disease in light of the phenomenon of protein intrinsic disorder and to look at the effects of disease-related mutations on protein disorder propensities and functionalities paying special attention to protein-protein interactions and posttranslational modifications (PTMs). The two most common types of inherited cardiomyopathy are hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
HCM is characterized by abnormal thickening of the heart wall, particularly affecting the left ventricle. Histologically, myocyte fibers of the HCM heart are hypertrophied and irregularly organized (Wigle et al., 1995; Hensley et al., 2015) . It is estimated that one in 500 people can be affected by HCM (Maron et al., 1995; Semsarian et al., 2015) . Most often, HCM is developed due to the genetic aberrations (mutations) in one of many sarcomeric genes encoding various myocardial contractile proteins, such as myosin heavy chain (MYH7), myosin-binding protein C (MYBPC3), cardiac troponin C (TnC, gene name TNNC1), cardiac troponin T (TnT, gene name TNNT2), and cardiac troponin I (TnI, gene name TNNI3) among others (Richard et al., 2003; Hensley et al., 2015) . The majority of HCM cases show autosomal dominant inheritance characteristics (Maron et al., 2003) . Clinically, HCM patients can remain asymptomatic throughout their life and free from any associated complications (Maron et al., 2014) . The disproportionate thickening of the left ventricular wall without chamber dilation leads to diastolic dysfunction and decreased cardiac output. Thickened walls also impair the ability of heart to conduct electrical signal, and, as a result, ventricular arrhythmia may arise in response to sports training (Rowland, 2009 ). This makes HCM, the most common cause of sudden death in young population (Hensley et al., 2015) .
DCM is characterized by the left ventricular systolic dysfunction secondary to the left ventricular dilation, which increases its mass and volume. Some patients also present with right ventricular dilation and dysfunction and left ventricular diastolic dysfunction (Jefferies and Towbin, 2010) . DCM is commonly subdivided into ischemic or non-ischemic. Common non-ischemic etiologies of DCM includes: coxsackievirus, alcohol abuse, some drugs (e.g. doxorubicin), pregnancy, and hemochromatosis. When all identifiable causes are excluded, the patient is diagnosed with idiopathic DCM (Hershberger et al., 2010; Hershberger et al., 2013) ; unfortunately, most DCM cases are idiopathic in etiology. It is believed that two out of three children with DCM have the idiopathic form of the disease (Towbin et al., 2006) . Clinically, DCM patients show systolic dysfunction and predisposition to congestive heart failure. Patients may show complications, such as mitral and tricuspid valve regurgitation and arrhythmia (Jefferies and Towbin, 2010; McNally et al., 2013) . As the disease worsens, a heart transplant becomes necessary in severe cases (Jefferies and Towbin, 2010) .
Troponin complex is the key component that regulates the on and off switch of cardiac muscle contraction. It is connected to the thin filament and consists of TnT that interacts with tropomyosin (Tm), TnC that binds Ca 2+ , and TnI that inhibits the ATPase activity of actomyosin complex. Cardiac muscle contraction is initiated by the increase in intracellular Ca 2+ levels and binding of this ion to TnC. However, the three troponin subunits work together as a complex, the structure of which changes conformation after binding of Ca 2+ . This allows myosin to interact with actin, with consumption of ATP, allowing muscle contraction (Katrukha, 2013) .
It is known that mutations in genes encoding sarcomere proteins accounts for most of the HCM and DCM cases (Kalyva et al., 2014; Messer and Marston, 2014) . Recent investigations have also shown that the physiological effects of troponin mutations associated with HCM and DCM are different. Impaired relaxation with significant increase in Ca 2+ sensitivity of force production has been shown for HCM mutations. In contrast, DCM mutations showed decreased Ca 2+ sensitivity of force production (Willott et al., 2010; Kalyva et al., 2014) . The key regulator of cardiac muscle contraction is the intracellular Ca 2+ level of the myocyte. When the intracellular Ca 2+ concentration is high (~10 -5 M), the muscle contracts and when the concentration is low (~10 -7 M), muscle relaxes. At the same intracellular Ca 2+ concentration, increased Ca 2+ sensitivity generates more muscle tension and the muscle remains hypercontracted and conversely, decreased Ca 2+ sensitivity generates reduced muscle tension (Kimura, 2010) . There is strong correlation between the mutations in each troponin subunit and the increase or decrease in the Ca 2+ sensitivity in HCM and DCM, respectively. We can clinically relate this to the hypercontractile characteristic in HCM and the systolic dysfunction in DCM (Kimura, 2010; Kalyva et al., 2014) .
Human cardiac troponin is a highly dynamic complex with structurally different subdomains connected by flexible linkers (Takeda et al., 2003) . This dynamic nature of the troponin complex suggests that its structure and function can be controlled by some features related to the phenomenon of protein intrinsic disorder. However, the exact role of intrinsic disorder in structure and function of this important protein complex as well as the effects of the cardiomyopathy-related mutation on the disorder propensity of its subunits have not been studied as of yet. To fill this gap and to find possible links among TnC, TnT, and TnI mutations and HCM and DCM, we computationally analyzed how intrinsic disorder propensities of the troponin subunits and their disorder-based functionalities are affected by the known mutations in these proteins.
The functionality of a protein has traditionally been believed to be linked to its unique, stable, three-dimensional structure. However, it is recognized now that the universe of functional proteins contains both ordered and intrinsically disordered entities, and therefore biologically active proteins can be ordered, partially-ordered, and completely disordered (Dunker et al., 1998 (Dunker et al., , 2000 Wright and Dyson, 1999; Uversky et al., 2000 Uversky et al., , 2005 Iakoucheva et al., 2002; Tompa, 2002 Tompa, , 2012 Uversky, 2002a Uversky, , 2015 Ward et al., 2004; Dyson and Wright, 2005; Radivojac et al., 2007; Uversky and Dunker, 2010; Habchi et al., 2014; van der Lee et al., 2014) . Each protein varies in its disorder content and flexibility, and this variability is determined by the peculiarities of protein amino acid sequences (Uversky et al., 2000; Uversky and Dunker, 2010; Uversky, 2013b; Habchi et al., 2014) . Intrinsic disorder accelerates interaction of proteins with their partners, defines functionality of chaperones, determines the predisposition of proteins for posttranslational modifications, is correlated with alternative splicing of RNA, and plays a role in various activities of DNA-and RNA-interacting proteins . Furthermore, intrinsically disordered proteins (IDPs) and intrinsically disordered protein regions (IDPRs) are promiscuous binders and play various important roles in protein complexes Uversky, 2015) . Although IDP and IDPRs are normally under very tight control, dysfunction on this control may result in the altered structure, perturbed functionality, and eventually progression to various pathologic conditions . Previous research has identified several disordered regions in proteins involved in the troponin complex (Hoffman et al., 2006; Hoffman and Sykes, 2008; Kowlessur and Tobacman, 2010a,b) .
The goal of this study was to investigate the association of the identified IDPRs in troponins with HCM and DCM. In other words, we hypothesized that some HCM-and DCMassociated mutations in TnC, TnT, and TnI could cause significant changes in the intrinsic disorder predisposition and/or binding propensity of proteins of the troponin complex. To test this hypothesis, we evaluated and compared the intrinsic disorder scores and binding propensities of the wild-type and disease-related variants of TnC, TnT, and TnI. Then, to investigate whether the mutationinduced changes in the intrinsic disorder scores or binding propensities are significantly enriched in the HCM-or DCM-associated cases, Fisher's exact test was applied. As this analysis did not revealed any meaningful relation between the HCM association and the score change patterns, the χ 2 goodness of fit test was applied to determine whether there is a difference in the proportions of smaller and greater scores causing variants. We showed that except to the TnC variations, mutations causing a decrease in the disorder score were significantly more abundant in both diseases than mutations leading to the increase in the disorder score. These observations suggested that the variants causing decrease in the intrinsic disorder score had greater propensity to cause diseases. Therefore, it is likely that those disease-causing mutations in troponins which are associated with the decreased local protein flexibility could trigger a whole plethora of functional changes ranging from muscle regulation to gene expression regulation. Furthermore, for the first time we identified the IDPRs in each of the troponin sub units, which can serve as the basis for the understanding of the roles of these regions in muscle regulation, as well as in interactome and posttranslational modifications of cardiac troponin.
Results
Structure and intrinsic disorder in the human cardiac troponin complex and in individual TnC, TnT, and TnI Figure 1 represents the crystal structure of the core of the human cardiac troponin complex (PDB ID: 1J1E) in
Figure 1: Analysis of the crystal structure of human cardiac troponin complex (PDB ID: 1J1E) in the Ca 2+ -saturated form that includes the full-length TnC protein (chains A and D) and fragments of TnT (residues 183-288, chains B and E) and TnI (residues 31-210, chains C and F) (Takeda et al., 2003) . The structure of the hexameric complex that contains chains A, B, C, D, E and F is sequentially disassembled to show structures of two TnCTnT-TnI trimers (chains A-B-C and D-E-F) and structures of individual monomers.
the Ca 2+ -saturated form that includes the full-length TnC protein and fragments of TnT (residues 183-288) and TnI (residues 31-210) (Takeda et al., 2003) . Figure 1 suggests that the cardiac troponin complex is a highly flexible entity that can be divided into several subdomains which are characterized by very different structural organization and are connected by flexible linkers (Takeda et al., 2003) .
The hypothesis on the high flexibility of proteins forming troponin complex was further supported by the analysis of the intrinsic disorder propensities of human troponins TnC, TnT, and TnI. Results of these analyses are shown in Figure 2 , which represents the per-residue disorder propensity of each individual human troponin evaluated by a family of PONDR predictors. Here, scores above 0.5 correspond to disordered residues/regions. Although PONDR ® VLXT is not the most accurate predictor, this tool possesses high sensitivity to local sequence peculiarities, which makes it useful for finding potential binding sites. PONDR ® VL3 is a tool for finding long disordered regions. PONDR ® VSL2 is one of the most accurate stand-alone disorder predictors, whereas PONDR-FIT is a metapredictor that is moderately more accurate than each of the component predictors. Figure 2 also represents the localization of potential disorder-based interaction sites predicted by two algorithms, ANCHOR and MoRFPred. According to these analyses, in their unbound (or monomeric) forms, all three human troponins are hybrid proteins that possess both ordered and disordered segments. Disordered segments have some local propensity for transient structure, and it is likely that these regions of local propensity for transient structure correspond to binding sites that fold at interaction with binding partners.
The D 2 P 2 database (http://d2p2.pro/) (Oates et al., 2013) contains information on predicted disorder and represents a versatile source of the important disorder-related functional information. In a visually attractive form, this database provides an access to the pre-computed disorder predictions (Oates et al., 2013 ) using outputs of PONDR ® VLXT , IUPred (Dosztanyi et al., 2005) , PONDR ® VSL2B Peng et al., 2006) , PrDOS (Ishida and Kinoshita, 2007) , ESpritz (Walsh et al., 2012) , and PV2 (Oates et al., 2013) . The visual console of D 2 P 2 is further enhanced by providing information on the curated sites of various PTMs and on the location of predicted disorder-based potential binding sites. Figure 3 are predicted to possess long disordered regions. Furthermore, Figure 3 shows that the IDPRs of these proteins possess multiple potential disorder-based binding motifs and numerous sites of various PTMs, such as phosphorylation, acetylation, methylation and ubiquitination. The observation that the disordered domains/regions of these proteins are heavily decorated by various PTMs is A C B Figure 3 : Evaluation of the functional intrinsic disorder propensity of human cardiac troponin I (UniProt ID: P19429), mouse cardiac troponin T (UniProt ID: P50752), and human cardiac troponin C (UniProt ID: P63316) (plots A, B, and C, respectively) by D 2 P 2 platform (http://d2p2.pro/) (Oates et al., 2013) . In the corresponding plots, top nine colored bars represent location of disordered regions predicted by different disorder predictors (Espritz-D, Espritz-N, Espritz-X, IUPred-L, IUPred-S, PV2, PrDOS, PONDR ® VSL2b, and PONDR ® VLXT, see keys for the corresponding color codes). Green-and-white bar in the middle of the plot shows the predicted disorder agreement between these nine predictors, with green parts corresponding to disordered regions by consensus. Yellow bar shows the location of the predicted disorder-based binding site (MoRF region), whereas red and yellow circles at the bottom of the plots show locations of phosphorylation and acetylation sites, respectively.
in agreement with the well-known fact that phosphorylation (Iakoucheva et al., 2004 ) and many other enzymatically catalyzed PTMs are preferentially located within the IDPRs (Pejaver et al., 2014) .
At the next stage, we further analyzed the interactivity of human troponins by the Search Tool for the Retrieval of Interacting Genes (STRING) platform that provides information on both experimentally validated and predicted interactions of query proteins (Szklarczyk et al., 2011) . STRING produces the network of predicted associations for a particular protein and its interactome. The network nodes are proteins, whereas the edges represent the predicted or known functional associations. Figure 4 represents the results of STRING analysis of human troponins and shows that these three proteins are expected to have very welldeveloped interactomes, and therefore can be considered as hub proteins in their functional protein-protein interaction networks (PPI). As the presented interactomes of troponin components are very large [ > 40 partners for TnI and TnT ( Figure 4A and B)], > 30 partners for TnC ( Figure 4C ), only information on some of the most prominent partners of each troponin component is presented below.
Obviously, TnI, TnT and TnC interact with each other to form cardiac troponin regulatory complex which is found in the thin filament and which defines the Ca 2+ -sensitivity of the ATPase activity of actomyosin in striated muscle. Besides binding to TnT and TnC, the troponin inhibitory subunit TnI is known to interact with actin, tropomyosin, and calcipressin-3 that binds to the catalytic domain of calcineurin A and inhibits the calcineurin-dependent transcriptional responses. Interaction of TnI with muscle-specific RING finger protein 1 (MuRF1), which is also known as E3 ubiquitin-protein ligase TRIM63 that functions as a component of the ubiquitin-proteasome system of protein degradation, leads to ubiquitination and subsequent degradation of TnI (Kedar et al., 2004) . Recently, it has been shown that the last five residues of cardiac TnI are important for binding of this protein to cardiac TnC and TnT and also play a role in the Ca 2+ -dependence of filament sliding (Gilda et al., 2016) . Figure 2 shows that this functionally important region of cardiac TnI is predicted to be disordered. Furthermore, according to the analysis of the crystal structure of cardiac troponin complex (PDB ID: 1J1E), the entire C-terminal tail (residues 191-209 and 162-209 in chains F and C, respectively) of this protein is missing, indicating its high mobility.
Cardiac TnT serves as the tropomyosin-binding and thin filament-anchoring subunit of troponin (Jin, 2016) . Curiously, two tropomyosin binding sites of were not resolved in the high resolution crystal structure of the cardiac troponin complex (Jin and Chong, 2010; Wei and Jin, 2016) , implicating the mostly disordered nature of these regions. These observations are in agreement with the results of the analysis of human cardiac TnT by ANCHOR algorithm that indicated the presence of seven potential disorder-based binding regions including those at residues 77-102, 107-121, 185-201, and 222-233 that overlap with known tropomyosin binding sites of TnT. In addition to serve as an anchor placing the troponin complex to the thin filament, TnT is known to directly interact with several proteins in the thin filament regulatory system (Perry, 1998) .
The major role of cardiac TnC is to respond to changes in calcium concentration. To fulfill this role, cardiac TnC evolved to have two Ca 2+ -binding EF-hand domains, the structural C-domain and the regulatory N-domain that are connected by a flexible linker and serve different functions (Li and Hwang, 2015) . In fact, open conformation of the C-domain, which is achieved due to the presence of two high affinity Ca 2+ -binding sites that, under physiologic conditions, are always occupied, provides means for anchoring TnC to the rest of the troponin complex (Li and Hwang, 2015) . The regulatory N-domain of this protein is preferentially in close conformation because it has a single low affinity site that is mostly unoccupied at resting calcium concentrations. However, the increase in the intracellular Ca 2+ levels that takes place at cardiac muscle activation ensures conditions for binding of this ion to the N-domain of cardiac TnC leading (cNTnC) to the formation of a conformation that binds to the switch region of TnI, removing adjacent inhibitory regions of TnI from actin and allowing muscle contraction to proceed (Li and Hwang, 2015) . Curiously, it has been indicated that contrarily to the regulatory N-domain of the skeletal muscle TnC (sNTnC) that is converted to the open conformation in the presence of calcium, the cNTnC remains mostly closed in both Ca 2+ -bound and apo-forms (Li and Hwang, 2015) .
The findings that human cardiac troponins contains substantial amounts of intrinsic disorder and are highly interactive are in agreement with the well-known fact that intrinsic disorder represents an important feature defining the ability of hub proteins to be promiscuous binders (Dunker et al., 1998; Uversky et al., 2005; Dosztanyi et al., 2006; Ekman et al., 2006; Haynes et al., 2006; Patil and Nakamura, 2006; Singh et al., 2006) . In fact, intrinsic disorder is always associated with the promiscuity of protein hubs, as many hubs are known to be intrinsically disordered or contain functional IDPRs, and when hubs are ordered, their partners are preferentially disordered (Dunker et al., 1998; Uversky et al., 2005; Dosztanyi et al., 2006; Ekman et al., 2006; Haynes et al., 2006; Patil and Nakamura, 2006; Singh et al., 2006) . , and human cardiac troponin C (UniProt ID: P63316) (plots A, B, and C, respectively) by STRING (Szklarczyk et al., 2011) . STRING produces the network of predicted associations for a particular protein and its interactome. The network nodes are proteins, whereas the edges represent the predicted or known functional associations. There are seven types of evidence used in predicting the associations which are indicated in the resulting network by the differently colored lines, where a red line indicates the presence of fusion evidence; a green line -neighborhood evidence; a blue line -co-occurrence evidence; a purple line-experimental evidence; a yellow line -text mining evidence; a light blue line-database evidence; a black line -co-expression evidence (Szklarczyk et al., 2011) . Table 1 lists TnC, TnI, and TnT disease-related variants analyzed in our study and shows changes introduced by these mutations on the PONDR-FIT disorder scores of these proteins at the mutation point. Supplementary Table S1 represents similar results for the TnC, TnI, and TnT mutants found in a healthy population and not associated with maladies to date. Tables 1 and S1 illustrate that the vast majority of SNPs cause local decrease in the disorder propensity, and some mutations have very noticeable effects (evaluated as a difference between the disorder scores calculated for the mutant and wild type proteins) on the Red and blue color indicates entries for which differences between the disorder scores calculated for the mutant and wild type proteins exceed the +/-0.100 threshold. "Red" entries are mutants that are significantly more disordered than the wild type protein, whereas "blue" entries show mutants that are significantly less disordered.
Intrinsic disorder change due to variants associated with HCM and DCM
local disorder propensity. We used a difference threshold of ±0.100 as the measure of the significant effect of each mutation on disorder score of the residue. For example, in TnC, the largest differences are introduced by diseaserelated mutations M103I (-0.177) and D75Y (-0.171) (Table  1) , and by mutations found in a healthy population I119T (+0.151), R102C (-0.112), D132N (-0.110), and D88N (-0.107). The D75Y mutation was present in association with the E59D mutation (E59D/D75Y), thus our data suggest that the D75Y might be the dominant variant. In TnI, the most disturbing disease-related mutations are R162W ( Values in brackets correspond to the residue-specific differences between the disorder scores of a given mutant and a wild type protein calculated at the mutation site. Negative numbers in brackets indicate mutations causing noticeable decrease in local disorder propensity, whereas positive numbers correspond to mutations leading to the increase in disorder score. However, Tables 1 and S1 also show that many mutations both disease-causing and disease-neutral have very marginal effects on the local disorder propensity. The presence of noticeable variability in the effects of different mutations on the disorder propensities of TnC, TnI, and TnT is further illustrated by Figure 5 and Supplementary Figures S1 and S2 where the disorder profiles generated for these proteins by several predictors of per-residue disorder predisposition are shown. Tables 1, S1 and S2 indicates that in three troponin components, there is an apparent accumulation of mutations that affect arginine (R). In fact, there are 5, 22, and 23 such mutations in TnC, TnI and TnT, respectively, and some arginine residues have multiple mutations. As a result, three of four arginines found in cardiac TnC are affected by mutations. In TnT and TnI 14 of 32 and 12 of 25 arginines are mutated. Curiously, Tables 1 and S1 emphasize that a third of the mutations in human cardiac TnT, TnI, and TnC affect arginine residues (28 of 75 mutations found in these proteins target arginines). On the contrary, mutations of lysine (K) are noticeably less abundant, although there are 13, 25, and 33 lysine residues in TnC, TnI, and TnT, respectively. Similar disproportionality is also observed for the mutations affecting negatively charged residues. In fact, in TnC, there are 10 aspartic acid (D) mutations that affect 9 of its 23 D residues (10-9-23) and just three glutamic acid (E) mutations affecting 3 of 23 residues (3-3-23). In TnI and TnT the situation is reversed, and the corresponding numbers are 3-3-13 and 2-2-25 for D residues, and 8-8-21 and 6-4-21 for E residues. One should keep in mind that the majority of these mutations are found in a healthy population and therefore are not associated with heart diseases.
These findings are in agreement with the results of previous study where it was demonstrated that diseaserelated mutations often cause local disorder-to-order transitions, and that the R→W, R→C, E→K, R→H, and R→Q substitutions accounts for 44% of all deleterious disorderto-order transitions (Vacic et al., 2012) . High mutability of arginine was also emphasized by other researchers (Steward et al., 2003; Vitkup et al., 2003) . It was pointed out that one of the potential mechanisms defining some of the arginine mutations can be related to DNA methylation (Vacic et al., 2012) that often occurs in a CpG dinucleotide context and due to spontaneous deamination of 5-methylcytosine might lead to the C→T mutation (Xia et al., 2012) . Since of six codons encoding arginine 4 contain the CG dinucleotide (CGG, CGT, CGC and CGA), the aforementioned methylation-driven C→T mutation in these codons would convert them to codons for W (TGG) or C (TGT, TGC) or create a stop codon (TGA) (Vacic et al., 2012) .
Plotting the intrinsic disorder scores of the variants and wild type troponins as described in the Methods ( Figure 5 and Supplementary Figures S1 and S2 ) revealed that the disease-associated mutations can cause diverse changes in the disorder distribution profiles of troponins. Comparison of the corresponding plots for the TnC, TnT, and TnI revealed that the TnT showed the most dynamic patterns of intrinsic disorder scores (cf. Figures 5, S1 , and S2). However, disorder plots shown in Figures 5, S1 , and S2 do not allow direct evaluation of the significance of changes in the disorder propensities caused by mutations. To address this issue, we conducted statistical analysis as described in the Materials and methods section (see Tables 1 and 2, and Supplementary Tables S3, S4, S5, and  a general Supplementary Table S11 ).
This analysis revealed that there was no strong evidence that the HCM-related mutations can generate oriented (or directed) changes in the intrinsic disorder propensity; i.e. changes where the disorder levels in the mutant proteins become systematically smaller or greater than the disorder levels in the corresponding wild type proteins, not only for the entire troponin complex, but also for the individual troponins (see Table 2 ). Although it was not tested specifically in our computational analysis, Tables S3, S4 , and S5). Tables S3, S4 , and S5). it could be inferred from the Fisher's exact tests' p-values that there was also no greater proportion of lower intrinsic disorder causing mutations in DCM cases. However, there was a significant correlation between the direction of the mutation-induced changes in the intrinsic disorder predisposition and the propensity of the mutations to induce either HCM or DCM. In fact, Table 3 shows that mutations causing reduction of the intrinsic disorder score are associated with the greater predisposition for these diseases. At the level of individual proteins, only TnC showed no significantly different proportions of mutations causing increase or decrease of the disorder scores, whereas TnT, TnI, and troponin complex showed significantly different proportions of such mutations. Furthermore, troponin complex, TnT, and TnI showed greater association with disease when mutations caused the decrease in the intrinsic disorder propensity. Therefore, these data suggest that in comparison with the TnC, the intrinsic disorder characteristics of the TnT and TnI are more sensitive to the disease-causing mutations. Overall, this analysis revealed that except to the TnC variations, mutations causing decrease in the disorder score were significantly more abundant in both diseases than mutations leading to the increase in the disorder score. Figure 6 illustrates the differences between the ability of the HCM-or DCM-causing mutations to induce significant changes in binding propensity of the corresponding proteins evaluated by the three computational tools for finding disorder-based potential binding sites. Among these three algorithms, MoRFpred provided a relatively smaller number of significant cases. ANCHOR and DisoRDPbind predictions for the TnT, and TnI showed relatively greater proportions of HCM cases than TnC. In the DCM cases, TnI showed relatively small counts of mutations causing significant changes in its binding propensity.
Category

PONDR-FIT PONDR-VLXT PONDR-VSL2
Category
PONDR-FIT PONDR-VLXT PONDR-VSL2
Binding propensity change due to variants associated with HCM and DCM
To further investigate this phenomenon, the variants were statistically analyzed as described in the Materials and methods section. Results of these analyses are summarized in Tables 4, 5, and Supplementary Tables S6, S7 , and S8. These analyses revealed that there was no significantly greater number of the HCM-associated variants that would cause increase in the binding propensities of human troponins (see Table 4 ). However, there were some proportional differences in binding propensities of variant proteins associated with HCM and DCM (see Table  5 ). Variants leading to higher MoRFpred score have an association with greater number of diseases. However, ANCHOR, and DisoRDPbind show non-significant proportional differences between binding propensity directions in the troponin complex and in individual proteins with the exception of ANCHOR data for TnI, which showed relatively smaller p-value (~0.09).
PTM changes due to sequence variations
PTM site predictions showed some changes between the wild type of each troponin and its variants. At the high confidence level, there were seven amino acid substitutions in these proteins that affected predisposition of mutated residues for PTMs: D2G mutation in TnC created N-terminal acetylation site; in TnI, K58N mutation created amidation site, K183E mutation created carboxylation site, and S199N and K207R mutations created proteolytic cleavage sites; and in TnT, new ubiquitination and disulfide linkage sites were created by E33K and R278C mutations, respectively. At the medium confidence level, R147C mutation in TnC eliminated ADP-ribosylation site; in TnI, I195M and A157V mutations eliminated amidation sites, K174N mutation created N-linked glycosylation site, K193N mutation created proteolytic cleavage site, whereas R74S, R192C, R204H, and E209K mutations removed ADPribosylation sites; in TnT, acetylation site was removed by K273E mutation, proteolytic cleavage site was created by R134G mutation, R84S, R84T, and R286H mutations eliminated ADP ribosylation sites. Again, many of these mutations are found in a healthy population and therefore are not associated with heart diseases. Supplementary Table S9 shows cases where SNPs affected PTM predictions within the entire protein, whereas Supplementary Table S10 shows the effect of SNPs on the protein regions containing PTMs using the SNP-centered window of 11 amino acids. From the viewpoint of the troponin complex, there were more chances of becoming highly scored PTM due to the sequence variations. In detail, only TnC showed a smaller number of mutated residues that became scored 'High' in PTM predictions, and a greater number of mutated residues with the decreased scores of PTM predictions. However, TnT, and TnI showed the opposite trend. Two proteins showed a greater predicted number of PTMs and were scored 'High' in corresponding PTM predictions (Table 6) .
To investigate the connectivity with the disease types (HCM and DCM), linear bar models of three proteins were constructed from the SNP point centered within the 11 amino acids' window ( Figure 7 ). All three bar models for troponin proteins showed a greater number of diseaseassociated SNPs that became 'High' scored PTMs. Among three proteins, TnC showed relatively even distribution between HCM-, and DCM-associated SNPs. However, TnT showed the characteristic pattern, where there was an association of N-terminal SNP with HCM and C-terminal SNP with DCM. In TnI (Pinto et al., 2011) , all of the diseaserelated SNPs were HCM-associated and were located at relatively far end of N-and C-termini. These observations suggest that TnC mutations do not affect the protein PTMs per se, but somehow they might hinder the TnC effect in other troponin subunits such as TnI (Pinto et al., 2011) . In contrast, TnI and TnT mutations modulate the predisposition of these proteins for PTMs and affect their PTM status.
Data presented in this section indicate that the number of predicted PTM for different troponin components is enormously large. Therefore, it is very desirable to compare these predictions with experimental results obtained by modern techniques. In agreement with our data, the mass-spectrometry-based analysis of the TnI samples extracted from human hearts showed a high degree of structural heterogeneity caused by various PTMS, such as phosphorylation, acetylation, proteolytic cleavage, and intrachain disulfide bond formation (Bunk et al., 2000) . Although troponin components are predicted to undergo different types of PTM and some PTMs were found in in vitro settings, it remains unknown whether all these PTM occurs in vivo. For example, cardiac TnT was shown to undergo extensive phosphorylation by different protein kinases at multiple sites in vitro (Streng et al., 2013) (with many of these in vitro found phosphorylation sites being similar to sites predicted in our study). However, mass-spectrometry analysis showed that only Ser1 of cardiac TnT is phosphorylated in vivo (Sancho Solis et al., 2008) . One should keep in mind though that the current lack of information on the in vivo phosphorylation at other sites does not necessarily mean that cardiac TnT is not phosphorylated at these sites. Also, the data on the effect of TnT phosphorylation on different types of heart diseases remain very controversial (Katrukha and Gusev, 2013; Streng et al., 2013) . Similar data were obtained for cardiac TnI. Although many sites of troponin I were predicted to be phosphorylated, and also it is known that this protein can be phosphorylated by protein kinase A (PKA) at Ser 22/23 and protein kinase C (PKC) at Ser 22/23 , Ser 42/44 , and Thr 143 (Dong et al., 2012) , 2/3 of phosphate incorporated in this protein belongs to Ser 22/23 (Marston and Walker, 2009) . Curiously, in the failing myocardium of the spontaneously hypertensive rats, cardiac TnI was shown to be hyperphosphorylated at Ser 22/23 and Ser 42/44 (Dong et al., 2012) , suggesting that augmented phosphorylation of this protein might be related to the pathogenesis of heart diseases. In addition, our computational analysis suggested that many sites in cardiac TnT and TnI can be acetylated or ubiquitinated, although there are studies showing that TnI is indeed ubiquitinated by MuRF1 (Kedar et al., 2004) and MuRF2 (Witt et al., 2005) , and TnT is also targeted by MuRF1 and MuRF2 (Witt et al., 2005) , the actual location of ubiquitination sites in these proteins is not known as of yet.
Discussion
Recent studies clearly indicated that not all biologically active proteins are structured, and that all proteomes studied so far contain numerous proteins that despite their lack of ordered structure possess numerous biological functions Dyson, 1999, 2009; Uversky et al., 2000 Uversky et al., , 2005 Dunker et al., , 2002a Dunker et al., ,b, 2005 Dunker et al., , 2008a Dunker and Obradovic, 2001; Wright, 2002, 2005; Tompa, 2002 Tompa, , 2005 Uversky, 2002a Uversky, ,b, 2003 Tompa and Csermely, 2004; Daughdrill et al., 2005; Oldfield et al., 2005 Oldfield et al., , 2008 Tompa et al., 2005 Tompa et al., , 2009 Radivojac et al., 2007; Vucetic et al., 2007; Xie et al., 2007a,b; Cortese et al., 2008; Dunker and Uversky, 2008; Russell and Gibson, 2008; Tompa and Fuxreiter, 2008; . Intrinsic disorder means conformational plasticity, which arms IDPs/IDPRs with a broad arsenal of means to be functionally superior and have numerous advantages over the functional modes of ordered proteins and domains (Wright and Dyson, 1999; Dunker et al., , 2002a Dunker et al., ,b, 2005 Dunker et al., , 2008b Wright, 2002, 2005; Uversky et al., 2005; Cortese et al., 2008; Dunker and Uversky, 2008; Oldfield et al., 2008; Uversky and Dunker, 2010) . For example, IDPs/IDPRs are very promiscuous binders that are constantly involved in various interactions with diverse partners (Uversky, 2011 (Uversky, , 2013a , are known to play key roles in protein-protein interaction networks Dosztanyi et al., 2006; Ekman et al., 2006; Haynes et al., 2006; Patil and Nakamura, 2006; Singh et al., 2006) . They possess specific identification regions utilized for partner recognition and binding, as well as for regulation and control of signaling pathways Uversky et al., 2005) . Various PTMs (such as phosphorylation, acetylation, methylation, lipidation, ubiquitination, sumoylation, etc.), which provide an efficient tool for the controllable modulation of biological functions, are known to be simplified in IDPs/IDPRs due to the high accessibility of their potential target sites Uversky, 2013a; Pejaver et al., 2014) . Also, disorder is crucial for formation, regulation and function of various protein complexes Uversky, 2015) . It was pointed out that in protein complexes, intrinsic disorder is used for several internal purposes, such as assembly, movement, and functional regulation of the different parts a given complex, and also has an important external use, defining the interaction of a complex with its external regulators (Uversky, 2015) . Furthermore, it was emphasized that IDPs/IDPRs are commonly involved in the pathogenesis of numerous human diseases and therefore should be considered as potential novel drug targets (Cheng et al., 2006; Dunker and Uversky, 2010; Metallo, 2010; Uversky, 2012) . In fact, disease-associated mutations were shown to disrupt functionally important regions of intrinsic protein disorder (Vacic et al., 2012) . Based on these premises, we analyzed the peculiarities of disorder distribution within the TnC, TnT, and TnI involved in the formation of the cardiac troponin complex and studied the effects of HCM-or DCM-causing mutations on disorder predisposition of these proteins leading to changes in their binding propensity and predisposition for PTMs.
We also analyzed several TnC, TnT, and TnI mutations found in a healthy population and therefore are not currently associated with heart diseases. Data on the effects of the disease-related mutations and mutations found in various cardiac troponins of a healthy population on the disorder propensity at the mutation point are shown in Table S1 and Figure 8 . Comparison of these data revealed that the disease-related mutations causing a decrease in the disorder score in TnI and TnT were more common than the analogous mutations found in a healthy population. In fact, among disease-associated mutations of TnI and TnT, 61.5% and 77.8%, respectively, were associated with the decrease in the disorder score at the mutation point, whereas the healthy population contained 50.9% and 63.2% such mutations in TnI and TnT, respectively. Also, Here, changes introduced by these mutations on the PONDR-FIT disorder scores of these proteins at the mutation point are calculated as Δ = variant-WT.
the overall amplitude of the negative changes introduced by the disease-associated mutations in TnC and TnT was noticeably greater than that introduced by the benign TnC and TnT mutations found in a healthy population. Therefore, on the global scale, it seems that there is a difference between the benign mutations found in a healthy population and the HCM-or DCM-causing mutations. On the other hand, Table S1 and Figure 8 show that some of the individual presumably benign mutations from a healthy population could change the disorder propensity as much as the individual disease-associated mutations, suggesting that disorder score alone may not be a good biomarker for distinguishing these two classes.
However, one should keep in mind that the current lack of association between the SNPs found in cardiac TnC, TnT, and TnI and heart maladies does not necessarily mean that these mutations are 'benign'. In fact, there is a very interesting case in the literature about an asymptomatic sperm donor, who had no personal knowledge of underlying heart disease and who underwent standard testing that was negative for infectious diseases, was used for several families for 2 years repeatedly. However, a few years later he developed HCM caused by a novel β-myosin heavy-chain mutation (Maron et al., 2009) . At least nine of the 24 offspring of the donor carry his mutation and three already have shown signs of cardiomyopathy (Maron et al., 2009 ). These observations suggest that very careful attention should be paid to the carriers of 'benign' mutations in cardiac troponins, as although samples were collected from a 'healthy' population cohort that did not show the presentation of the disease, one cannot exclude the possibility that some of these mutations could be found to be associated with cardiomyopathy in the future.
We found that all three proteins are predicted to have significant levels of intrinsic disorder, with the TnT being predicted to be most disordered member of the troponin complex, followed by TnC and TnI (see Figure 2) . This is in a good agreement with known experimental data. Curiously, application of the amide hydrogen exchangemass spectrometry for mapping of the dynamic properties of cardiac troponin revealed that all three chains (residues 2-161, 3-210, and 183-288 of TnC, TnI, and TnT, respectively) have long regions of high mobility, which are poorly protected from the H/D exchange both in the absence and presence of calcium (Kowlessur and Tobacman, 2010b) . In fact, this analysis revealed that more than have of the analyzed amide hydrogens (53%) are completely unprotected within the troponin complex (Kowlessur and Tobacman, 2010b) . It was pointed out that although some of such fast exchanging hydrogens were located within the known disordered regions of troponin, many of those fast-exchanging hydrogens were found in regions with known 3D structures, emphasizing the loose packing of these proteins within the troponin complex (Kowlessur and Tobacman, 2010b) . Subsequent analysis of the dynamics of the Ca 2+ -saturated cardiac troponin core domain (TnC/TnI/TnT 183−288 ) at low temperature (10°C) using H/D exchange-mass spectrometry provided further support for the presence of noticeable flexibility in this complex (Kowlessur and Tobacman, 2010a) . For example, TnI was shown to have several flexible regions with no or low protection: residues 1-40, 60-70, 125-152, and 162-210; in TnC, regions with highly dynamic behavior were found within the N-and C-terminal domains, and for several central regions; in TnT 183−288 , high mobility was found in N-and C-terminal regions (Kowlessur and Tobacman, 2010a ). Finally, using same H/D exchange-mass spectrometry-based technique it was shown that the cardiomyopathy-linked mutations were predominantly found within flexible regions of troponin (Kowlessur and Tobacman, 2012) .
Information about structural properties and disorder status of individual troponin chains is mostly limited to TnI, which was shown to have functionally important IDPRs (Hoffman et al., 2006; Hoffman and Sykes, 2008; Julien et al., 2011; Hwang et al., 2014) . Unfortunately, much less is currently known about prevalence of intrinsic disorder in TnC and TnT alone because of noticeable experimental restrictions. For example, the biggest challenge in studying TnT structure is that this protein is not soluble even in the presence of high salt concentrations and therefore cannot be easily analyzed by NMR. Also, high natural flexibility of TnT (especially flexibility of the tail domain TnT1) precludes its crystallization, making the full-length protein unavailable for structural studies. TnC is also very flexible, and most of the structures available for this protein were obtained in the presence of Ca 2+ and Ca 2+ sensitizer to stabilize the protein. Therefore, it seems that at the moment, the computational analysis similar to one conducted in our study represents a logical approach to answer the question on structural properties of these proteins.
Our analyses also suggested that TnC, TnI, and TnT might have several PTM sites. In agreement with these predictions, an analysis of the cardiac TnI purified from human heart tissue using the top-down high-resolution tandem mass spectrometry in conjugation with immunoaffinity chromatography purification revealed a high degree of heterogeneity of this protein, with sample containing isoforms produced by phosphorylation, acetylation, oxidation, and C-terminal proteolysis (Zabrouskov et al., 2008) . A similar approach showed that cardiac TnI isolated from domestic pig hearts was phosphorylated and N-terminally acetylated (Zhang et al., 2010) and that phosphorylation is conserved in human and mouse cardiac TnIs (Zhang et al., 2011) . Even more impressively, high-resolution top-down Fourier transform ion cyclotron resonance (FT-ICR) MS analysis of the cardiac TnI sample purified from healthy human heart tissues revealed a total of 36 proteoforms resulting from acetylation, phosphorylation, oxidation and proteolytic degradation of this protein (Peng et al., 2014) .
Our analysis also shows that the HCM-and DCM-associated mutations in cardiac troponins affected the PTM maps of these proteins. This is an important observation which is in accord with current knowledge emphasizing that the phosphorylation sites in sarcomeric proteins are altered in cardiomyopathy and other heart diseases. For example, it has been shown that the efficiency of phosphorylation of cardiac TnI at 14 positions is noticeably altered in heart failure . Here, the extents of phosphorylation at the protein kinase A sites (S22, S23) and sites located within the N-terminal cardiac extension of TnI (S4, S5, Y25) were noticeably decreased, whereas the extents of phosphorylation at the protein kinase C sites (S41, S43, T142), and sites at the IT-arm domain (S76, T77) and C-terminal domain (S165, T180, S198) were significantly increased . Also, an analysis of the HCM-associated mutations in cardiac TnI revealed that despite the fact that two such mutations, R21C and R146G, are located in TnI different regions, within the cardiac-specific N terminus and the inhibitory peptide, respectively, both of them reduced the efficiency of the TnI phosphorylation at the S23/S24 position (Gomes et al., 2005; Wang et al., 2012; Cheng et al., 2015) .
Materials and methods
Intrinsic disorder and binding propensity change due to variations
To measure the significance of each variation's intrinsic disorder and binding propensity change, sequences of three types of troponin subunits; TnC, TnT, and TnI are obtained from UniProt 2015_04 (Apweiler et al., 2004) . Their UniProt IDs (ENSEMBL transcript IDs) are P63316 (ENST00000232975), P45379-6 (ENST00000367318), and P19429 (ENST00000344887), respectively. Then, each protein's variant list was obtained from the database ENSEMBL (Release 79) and three previous research papers (Hubbard et al., 2002; Willott et al., 2010; Kalyva et al., 2014; Alfares et al., 2015) . In detail, the list of TnC was obtained from the ENSEMBL, and Kalyva et al. (Hubbard et al., 2002; Kalyva et al., 2014) , TnT variation list was obtained from Willott et al. and Alfares et al. (Willott et al., 2010; Alfares et al., 2015) , and the TnI variation list was obtained from the ENSEMBL, and Willot et al. (Hubbard et al., 2002; Willott et al., 2010) . Based on the lists, variant sequences were prepared using Python 3 programming.
All wild type and variant sequences were analyzed for intrinsic disorder propensity by three different algorithms, PONDR-FIT (Xue et al., 2010) , PONDR-VSL2 Peng et al., 2005) , and PONDR-VLXT (Li et al., 1999; Romero et al., 2001) . Binding propensities of these proteins were evaluated by three algorithms, MoRFpred, ANCHOR, and DisoRDPbind Meszaros et al., 2009; Disfani et al., 2012; Peng and Kurgan, 2015) . We also distinguished variants associated with HCM or DCM according to Willott et al. (2010) and Kalyva et al. (2014) . Although Alfares et al. (2015) described some HCM-associated variants, we did not assign HCM or DCM association based on their research, because it only dealt with HCM, and there are some variants, which were known to be associated with DCM.
To verify whether variants cause significant changes in the binding propensity, the corresponding per-residue scores of each variant were compared with the scores of the wild type protein using the Wilcoxon signed rank test. The 1-tailed test p-values were obtained through Python 3 programming and its modules, NumPy and SciPy, based on hypothesis 1 and 2: 
For evaluation purposes, the hypothesis H 0 was rejected if the corresponding p-value was less than a-level of 0.05, and, therefore, the corresponding variant score was considered to be significantly greater than the score of the wild type protein. According to the statistics distribution, if p-value was > 0.95, it was understood as the variant score being significantly smaller than that of the wild type protein.
Next, we verified whether the changes in the intrinsic disorder scores induced by the variants were significantly less than a -wild type in HCM cases (hypothesis 3-4). Thus, we established 2 × 2 contingency tables for all proteins (troponin complex) (see Supplementary  Tables S3, S4 , S5, and a general Supplementary Table S11). As smaller intrinsic disorder scores within and IDPR could cause greater binding propensity, the 2 × 2 contingency tables for the analysis of changes in the binding propensity were constructed using hypothesis 5 and 6 (see Supplementary Tables S3, S4, S5, and a general Supplementary  Table S11 ). To verify the hypothesis below (3-6), we applied 1-tailed Fisher's exact test using R 3.1. The results were evaluated based on the p-values at the a-level of 0.05.
For intrinsic disorder changes: 
To check whether there is a difference of the proportions of the smaller and greater score changes in both diseases without distinction of types, we applied chi-square goodness of fit test using R 3.1 based on the hypotheses 7-10 below. 
Post-translational modifications (PTM) change due to variations
The amino acid sequences of the wild type and mutant troponin proteins TnC, TnT, and TnI were used to predict their predispositions for the PTMs using ModPred Windows OS User-interface version (Pejaver et al., 2014) . Then, the related propensities of each wild type residue were compared to those of corresponding mutated residue of each variant using the Python 3 programming. In this analysis, we used only high confidence cases; i.e. cases corresponding to the scenarios where mutations induced changes to or from 'High' confidence in a wild type protein (Supplementary Table S8 ). To investigate further, we focused on the cases where the positions were directly affected by mutations (SNPs). We also looked at the effect of SNPs on the protein regions containing PTMs using the SNP-centered window of 11 amino acids (see Supplementary Table S9 ).
